Robin Shane Readnour, Dir at An2 Therapeutics, Inc., Sells Shares Worth $6,675

An2 Therapeutics, Inc. (ANTX) disclosed that Robin Shane Readnour, who holds the position of Dir at the company, was involved in selling 1,108 shares, per a Form 4 filing with the SEC.

The transaction was executed at a price of $6.02 per share, for a total value of approximately $6,675.

Company insiders are required to disclose changes in their stock ownership to the SEC on Form 4, typically within two business days of the trade.

Insider sales are common and can occur for reasons unrelated to a company's outlook, including scheduled trading plans, diversification, or personal financial planning.